PSNL Personalis Inc

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Matinas BioPharma (MTNB – Research Report), Seres Therapeutics (MCRB – Research Report) and Personalis (PSNL – Research Report) with bullish sentiments. Matinas BioPharma (MTNB) H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Matinas BioPharma today and set a price target of $3.00. The company's shares closed last Wednesday at $0.78. According to TipRanks.com, Fein has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -12.7% and a 29.2% success rate.
https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-matinas-biopharma-mtnb-seres-therapeutics-mcrb-and-personalis-psnl?utm_source=advfn.com&utm_medium=referral